Arbor Hits FDA With Suit Over Neurological Drug

Arbor Pharmaceuticals LLC has launched a lawsuit in Georgia federal court challenging a U.S. Food and Drug Administration finding that the company said would allow for more generic versions of a...

Already a subscriber? Click here to view full article